Literature DB >> 11156939

Cell cycle-dependent expression of cyclooxygenase-2 in human fibroblasts.

D W Gilroy1, M A Saunders, L Sansores-Garcia, N Matijevic-Aleksic, K K Wu.   

Abstract

The purpose of this investigation is to determine whether the levels of cyclooxygenase-2 (COX-2) expression are cell cycle dependent. We used a serum-starved human foreskin fibroblast model to determine changes in COX-2 mRNA, protein, and promoter activity in response to stimulation with interleukin-1b (IL-1b) and phorbol 12-myristate 13-acetate (PMA) at G0, G1, S and G2/M phases of the cell cycle. IL-1b (1 ng/ml) and PMA (100 nM) induced robust COX-2 expression in the G0 cells, and the level of COX-2 expression declined progressively after the cells had entered the cell cycle. The COX-2 mRNA level at G1, S and G2/M phases of the cell cycle was 76%, 46%, and 30% of that at G0, respectively. A 5-flanking promoter fragment of COX-2 constructed into a luciferase expression vector was transfected into cells. The promoter activity in response to PMA stimulation was significantly higher in G0 than in S phase cells. These results imply that G0 cells are the key players in inflammation and other COX-2-dependent pathophysiological processes. When the cells are in the proliferative phase, COX-2 inducibility becomes restrained probably by an endogenous control mechanism to avoid COX-2 mediated oxidative DNA damage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11156939     DOI: 10.1096/fj.00-0573fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  9 in total

1.  Glucocorticoids suppress hypoxia-induced COX-2 and hypoxia inducible factor-1α expression through the induction of glucocorticoid-induced leucine zipper.

Authors:  Wonchung Lim; Choa Park; Myeong Kuk Shim; Yong Hee Lee; You Mie Lee; YoungJoo Lee
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

2.  Disruption of CTCF/cohesin-mediated high-order chromatin structures by DNA methylation downregulates PTGS2 expression.

Authors:  J Y Kang; S H Song; J Yun; M S Jeon; H P Kim; S W Han; T Y Kim
Journal:  Oncogene       Date:  2015-02-23       Impact factor: 9.867

3.  Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARgamma : Possible relevance to human fibrotic disorders.

Authors:  Mónica B Frungieri; Stephan Weidinger; Viktor Meineke; Frank M Köhn; Artur Mayerhofer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-23       Impact factor: 11.205

4.  Control of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoxytryptophan.

Authors:  Huei-Hsuan Cheng; Cheng-Chin Kuo; Jiann-Long Yan; Hua-Ling Chen; Wei-Chung Lin; Kai-Hsuan Wang; Kelvin K-C Tsai; Hayrettin Guvén; Emilie Flaberg; Laszlo Szekely; George Klein; Kenneth K Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-31       Impact factor: 11.205

5.  Induced mitogenic activity in AML-12 mouse hepatocytes exposed to low-dose ultra-wideband electromagnetic radiation.

Authors:  W C Dorsey; B D Ford; L Roane; D T Haynie; P B Tchounwou
Journal:  Int J Environ Res Public Health       Date:  2005-04       Impact factor: 3.390

Review 6.  Cytoguardin: A Tryptophan Metabolite against Cancer Growth and Metastasis.

Authors:  Kenneth K Wu
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

7.  Cooperative effects of matrix metalloproteinase and cyclooxygenase-2 inhibition on intestinal adenoma reduction.

Authors:  R A Wagenaar-Miller; G Hanley; R Shattuck-Brandt; R N DuBois; R L Bell; L M Matrisian; D W Morgan
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

8.  Quiescent fibroblasts are more active in mounting robust inflammatory responses than proliferative fibroblasts.

Authors:  Bo-Rui Chen; Huei-Hsuan Cheng; Wei-Chung Lin; Kai-Hsuan Wang; Jun-Yang Liou; Pei-Feng Chen; Kenneth K Wu
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

9.  Quiescent and proliferative fibroblasts exhibit differential p300 HAT activation through control of 5-methoxytryptophan production.

Authors:  Huei-Hsuan Cheng; Kai-Hsuan Wang; Ling-yun Chu; Tzu-Ching Chang; Cheng-Chin Kuo; Kenneth K Wu
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.